Cargando…
A review of safety incidents in England and Wales for vascular endothelial growth factor inhibitor medications
PURPOSE: To learn from patient safety incidents (PSIs) following recent introduction of vascular endothelial growth factor inhibitor medications (anti-VEGF) in ophthalmic care, as reported via a national incident reporting database. METHODS: Thematic retrospective review of anti-VEGF medications PSI...
Autores principales: | Kelly, S P, Barua, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3178143/ https://www.ncbi.nlm.nih.gov/pubmed/21527957 http://dx.doi.org/10.1038/eye.2011.89 |
Ejemplares similares
-
QTc interval prolongation with vascular endothelial growth factor receptor tyrosine kinase inhibitors
por: Ghatalia, P, et al.
Publicado: (2015) -
Joint Assessment of Intended and Unintended Effects of Medications: An Example Using Vascular Endothelial Growth Factor Inhibitors for Neovascular Age-Related Macular Degeneration
por: Levy, Adrian R., et al.
Publicado: (2009) -
Interval cancers in the NHS breast cancer screening programme in England, Wales and Northern Ireland
por: Bennett, R L, et al.
Publicado: (2011) -
Vascular Endothelial Growth Factor in Tear Samples of Patients
with Systemic Sclerosis
por: Rentka, Anikó, et al.
Publicado: (2015) -
Vascular Endothelial Growth Factor and Brain-Derived Neurotrophic Factor in Quetiapine Treated First-Episode Psychosis
por: Murphy, Brendan P., et al.
Publicado: (2014)